20
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
TP2252 | GLP-1 (9-36) amide | Glucagon Receptor | |
antagonist at the human GLP-1 receptor | |||
T37890L | GLP-1(28-36)amide acetate | GLP-1(28-36)amide acetate(1225021-13-5 Free base) | Antioxidant , Glucagon Receptor |
GLP-1(28-36)amide acetate inhibits mitochondrial permeability transition with antioxidant, anti-diabetic and cardioprotection activities. | |||
T37891L | GLP-1(32-36)amide acetate | GLP-1(32-36)amide acetate(1417302-71-6 Free base) | Others |
GLP-1(32-36)amide acetate is a pentapeptide and derived from the C terminus of the glucoregulatory hormone GLP-1. GLP-1(32-36)amide acetate could inhibit weight gain and modulate whole body glucose metabolism in diabetic... | |||
T3984 | GLP-1(7-36), amide | MKC 253,Human GLP-1-(7-36)-amide,Glucagon-like Peptide 1 (7-36) amide,Glucagon-Like Peptide (GLP) I (7-36), amide, human,GLP-1(7-36),GLP-1-(7-36)-amide | Glucagon Receptor |
GLP-1(7-36), amide (MKC 253) is a peptide hormone released from intestinal L-cells upon nutrient consumption. It binds the GLP-1 receptor in the pancreas and displays various antidiabetic effects by potentiating glucose-... | |||
T37891 | GLP-1(32-36)amide | ||
GLP-1(32-36)amide is a pentapeptide compound derived from the C terminus of the glucoregulatory hormone GLP-1. This compound has shown potential in inhibiting weight gain and regulating glucose metabolism in diabetic mic... | |||
T37890 | GLP-1(28-36)amide | ||
GLP-1(28-36)amide, a C-terminal nonapeptide derived from the cleavage of GLP-1 by neutral endopeptidase (NEP), is a significant product. It functions as an antioxidant and primarily targets the mitochondrion, where it ef... | |||
T37892 | GLP-1(7-36), amide TFA | ||
GLP-1(7-36), amide TFA is a prominent intestinal hormone known to stimulate glucose-induced insulin secretion from β cells[1]. | |||
T36380 | GLP-1 (1-36) amide (human, rat) (trifluoroacetate salt) | ||
GLP-1 amide is a peptide hormone cleaved from proglucagon in the pancreas.1,2 Mice lacking the glucagon receptor (Gcgr-/-) have approximately nine-fold higher levels of total GLP-1 amide, including GLP-1 (1-36) amide and... | |||
TP1141 | GLP-1(7-36), amide acetate | GLP-1(7-36) Acetate,Human GLP-1-(7-36)-amide Acetate | |
GLP-1(7-36) Acetate is a major intestinal hormone that stimulates glucose-induced insulin secretion from β cells. | |||
T80453 | GLP-1 (1-36) amide (human, rat) | Glucagon-like Peptide 1 (1-36) amide (human, rat) | |
GLP-1 (1-36) amide (human, rat) is a molecular variant of the GLP-1 (7-36) amide and has the capacity to stimulate [14C]aminopyrine accumulation in enzymatically dispersed, enriched rat parietal cells [1]. | |||
T75822 | GLP-1(9-36)amide TFA | ||
GLP-1(9-36)amide TFA, a predominant metabolite of glucagon-like peptide-1-(7-36)amide synthesized through dipeptidyl peptidase-4 (DPP-4) activity, functions as an antagonist to the human pancreatic GLP-1 receptor [1] [2]... | |||
T76192 | GLP-1(32-36)amide TFA | ||
GLP-1(32-36)amide TFA, originating from the C-terminal end of the glucoregulatory hormone GLP-1, is a pentapeptide that has demonstrated the ability to mitigate weight gain and regulate glucose metabolism throughout the ... | |||
T76191 | GLP-1(28-36)amide TFA | ||
GLP-1(28-36)amide TFA, a C-terminal nonapeptide derived from GLP-1 cleavage by neutral endopeptidase (NEP), acts as an antioxidant targeting mitochondria. It inhibits mitochondrial permeability transition (MPT), exhibiti... | |||
T82309 | GLP-1 (1-36) amide (human, rat) (TFA) | Glucagon-like Peptide 1 (1-36) amide (human, rat) (TFA) | |
GLP-1 (1-36) amide (human, rat) TFA, a molecular variant of GLP-1 (7-36) amide, can induce [14C]aminopyrine accumulation in enzymatically dispersed enriched rat parietal cells [1]. | |||
T76333 | (Ser8)-GLP-1 (7-36) amide, human | ||
(Ser8)-GLP-1 (7-36) amide, human is a glucagon-like peptide-1 amide originating from glucagonogen, itself a cleavage product of the GLP-1 (1-36) amide peptide. This entero-insulinotropic hormone facilitates glucose-depen... | |||
T76085 | Glucagon-Like Peptide 1 (GLP-1) (7-36)-Lys (Biotin), amide, human | ||
Glucagon-Like Peptide 1 (GLP-1) (7-36)-Lys (Biotin), amide, human, is a human GLP-1 (7-36) amide that has been biotinylated at the C-terminal. | |||
TP2100 | Avexitide | Exendin-3 (9-39) amide,Exendin (9-39) | Glucagon Receptor |
Avexitide (Exendin-3 (9-39) amide) (Exendin (9-39)) is a specific and competitive antagonist of glucagon-like peptide-1 (GLP-1) receptor. | |||
TP1452 | HAEGTFTSD | ||
HAEGTFTSD is the first N-terminal 1-9 residues of GLP-1 peptide.The GLP-1 (7-36) amide is a product of the preproglucagon gene, which is secreted from intestinal L-cells, in response to the ingestion of food. | |||
TP1452L1 | HAEGTFTSD acetate(926018-45-3 free base) | Glucagon Receptor | |
HAEGTFTSD acetate is the first N-terminal 1-9 residues of GLP-1 peptide.The GLP-1 (7-36) amide is a product of the preproglucagon gene, which is secreted from intestinal L-cells, in response to the ingestion of food. | |||
T37522 | Teneligliptin | ||
Teneligliptin (MP-513) is a potent chemotype prolylthiazolidine-based DPP-4 inhibitor, which competitively inhibits human plasma, rat plasma, and human recombinant DPP-4 in vitro, with IC50s of approximately 1 nM. Teneli... |